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During immune responses, naive CD8 T cells 
are called on to develop multiple activities re-
quired to control antigen load, as well as to gen-
erate memory cells able to respond effi   ciently 
to rechallenge. All of these events are initiated 
by TCR triggering and occur within a very 
limited time frame. Addressing how these dif-
ferentiation programs are established is of great 
interest to understand the establishment of suc-
cessful immunity.
Most studies evaluating gene expression after 
T cell activation used in vitro–activated CD4 or 
CD8 T cells (1, 2) and studied cytokine expression 
directly or through the use of reporter genes. In 
both circumstances, IL-2 was induced before 
any division, and the Th1 or Th2   diff  erentiation 
patterns were imprinted through successive 
divisions. Although these and other studies con-
tributed signifi  cantly to delineate Th1–Th2 dif-
ferentiation pathways (3), they appeared not to 
mimic in vivo CD8 diff  erentiation because the 
induction of killer genes was not addressed and 
CD8 T cells were never reported to develop 
a Th2 cytokine profi  le during in vivo immune 
responses. Concerns were also raised on other 
possible diff  erences between in vitro and in vivo 
environments. It was shown that the normal 
organ three-dimensional structure could signif-
icantly modify CD8 responses (4). It was also 
shown that in vitro restimulation could alter 
in vivo readouts; IFN-γ expression frequencies 
of 10% evaluated ex vivo were shown to in-
crease to 90% (5), and TNF-α expression fre-
quencies changed from <1% to 100% after a 
4-h peptide stimulation in vitro (6). Also, inef-
fi  cient or abortive immune reactions leading to 
deletion or anergy scored similarly to effi   cient 
memory cells in certain conditions of in vitro 
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T cell stimulation (7, 8). These diff  erences between in vitro 
and in vivo data raise the possibility that during an in vivo 
response, CD8 T cells may never meet the peptide or cyto-
kine concentrations used to diff  erentiate them in vitro. Con-
versely, the in vivo context may provide multiple additional 
environmental clues that may not be mimicked in in vitro 
cultures. Therefore, we aimed to directly study the induc-
tion of gene expression and gene association in CD8 T cells 
throughout immune responses in vivo, and considered the 
best approach to reach such an aim.
Diff  erentiation programs involve the modifi  cation of the 
expression of multiple genes, which concur to defi  ne new 
cell properties. Because the induction of each gene expres-
sion requires multiple modifi  cations to occur in the same cell 
(the induction/activation of signaling components, transcrip-
tion factors, etc.), initiation of gene transcription is governed 
by probability laws, i.e., it is stochastic (for review see refer-
ence 9). New genes may be induced diff  erently in each indi-
vidual cell in such a way that each cell may express diff  erent 
amounts of the same gene and/or diff  erent gene combina-
tions. To study such cell–cell variation, one should be able to 
quantify each mRNA type in each individual cell. Because 
the direct quantifi  cation of gene expression at a single cell 
level was thought impossible (10), studies of the induction of 
gene expression used reporter transgenes to quantify indi-
rectly gene expression levels in single cells. These studies 
confi  rmed the stochasticity of gene induction (for review see 
reference 9). However, because knock-in technology does 
not yet allow multiple gene labeling, reporter genes could 
not be used to evaluate the establishment of diff  erentiation 
programs that involve the coexpression of several genes by 
the same cell. It is possible that coexpression of diff  erent 
genes by the same cell is also stochastic. However, in the ab-
sence of available data, an elegant hypothesis was put forward 
(11). Because all CD8 eff  ector molecules share several regula-
tory elements, it was proposed that once an individual cell 
would acquire some of these components any de novo ex-
pressed gene would be expressed preferentially in that cell 
(11). However, this hypothesis does not take into account that 
many of the regulatory components known to be involved 
in CD8 diff  erentiation (Eomes, NFAT, NF-κB, Ikaros, etc.) 
(11) are not really CD8 specifi  c, but are shared by several alter-
native diff  erentiation pathways.
In this context, we thought the best way to evaluate puta-
tive cell heterogeneity during in vivo CD8 diff  erentiation 
was to study individual cells throughout immune responses, 
and to quantify the expression of several genes simultaneously 
in each individual cell. We developed a methodology over-
coming the multiple limitations preventing the direct quanti-
fi  cation of multiple gene expression in single cells, and showed 
that we may now study 20 diff  erent genes simultaneously in 
each cell and accurately quantify 2–109 mRNA copies of 
each gene (10). In this study, we characterized two putatively 
diff  erent immune reactions that originate effi   cient CD8 
memory: the response of anti-HY TCR-transgenic (Tg) cells 
to the male antigen (5, 12, 13) and of OT-1 naive TCR-Tg 
cells to Listeria monocytogenes OVA (14). We isolated individ-
ual cells at the diff  erent points of each immune reaction. In 
each cell, we simultaneously evaluated the expression of 14 
T-cell eff  ector genes, as well as several receptors for cytokines 
and chemokines reported to infl  uence CD8 responses. This 
extensive single-cell study showed that both responses were 
similar, but that gene expression patterns were quite complex. 
Diff  erent eff  ector genes were induced at diff  erent time points 
of the response, transcribed during diff  erent time periods, and 
could decline or persist independently of antigen. This hetero-
geneous behavior revealed CD8 types with diff  erent gene 
coexpression patterns and diff  erent in vivo behavior that were 
present at diff  erent phases of the response.
Globally, these data show how multiple genes important 
to CD8 function are induced and associate through the im-
mune response and redefi  ne diff  erent functional properties of 
CD8 T cells at the diff  erent phases of the immune reaction. 
We also show that, like B cells, CD8 T cells eventually dif-
ferentiate into long-lived eff  ectors after boosting that persists 
in vivo in the absence of antigen. In this context, this data also 
has a particular relevance to the discussion of what an   eff  ector 
or a memory T cell is.
RESULTS
Experimental approach
We isolated individual naive or primed TCR-Tg cells at 
  diff  erent points of the immune response to male cells or to 
L. monocytogenes OVA stimulation. To ensure that all cells we 
studied had been stimulated by antigen, they were labeled 
with CFSE before “in vivo” transfer. In the fi  rst 24 h after “in 
vivo” activation, we selected CD69+ cells that had not diluted 
CFSE because antigen-specifi  c cells do not divide (5). At later 
time points, CD69 is down-regulated, but we ensured that all 
cells studied had diluted CFSE labeling, i.e., were stimulated 
and divided in response to antigen. The following points were 
selected: the early expansion phase, before exponential T cell 
growth (primary early expansion CD8s [PE-CD8s]); the peak 
of the exponential T cell growth (primary peak expansion 
CD8s [PP-CD8s]); the plateau of the response (primary pla-
teau CD8s [PL-CD8s]); and at diff  erent time points of the 
memory stage (primary memory CD8 [PM-CD8]). Each in-
dividual cell was screened for the coexpression of 14 eff  ector 
genes (Supplemental text, available at http://www.jem.org/
cgi/content/full/jem.20062349/DC1). Th2/ T-cytotoxic 2 
(Tc2) genes were never expressed. In contrast to in vitro CD8 
activation, the expression of Il2 and Il10 was so rare that ex-
pression frequencies could not be estimated at the single-cell 
level. Eight remaining eff  ector genes were expressed frequently. 
Because gene expression was similar in both responses, we 
describe fi  rst the anti-HY response in detail and show the anal-
ogies of the anti-OVA response after.
Individual effector genes have different kinetics 
of induction/down-regulation/coexpression
Naive anti-HY cells do not express eff  ector molecules, with 
the exception of occasional cells expressing Tgfb1 (5). After in JEM VOL. 204, May 14, 2007  1195
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vivo activation, each eff  ector gene had a diff  erent behavior. 
“Infl  ammatory” mediators were induced early upon activa-
tion. Surprisingly, their expression was transient, being down-
regulated while CD8 T cells were still expanding vigorously. 
The Tgfb1 was up-regulated at 7 h (unpublished data) and 
maximal frequency (70%; Fig. 1) and mRNA copies/cell (Figs. 
1 and 2) were found in early expansion PE-CD8s, both de-
clining thereafter. The Tnf was also induced at 7 h, but its 
expression down-regulated even earlier, before the expo-
nential expansion phase (unpublished data). In contrast, the 
classical CD8 eff  ector molecules were poorly expressed in 
PE-CD8s. Although PE-CD8s already have diluted CFSE 
labeling, demonstrating that they divided extensively (5), 
they rarely expressed Ifng or Fasl. Individual PE-CD8s could 
express Prf, Gzma, or Gzmb, but these molecules were rarely 
coexpressed by the same cell. These results suggested that 
PE-CD8s were not cytotoxic because target cell elimination 
through the perforin pathway requires the coexpression 
of perforin and granzymes by the same cell (for review see 
reference 15). Moreover, only few expressed Fasl, and killing 
mediated by FasL alone is not effi   cient (15, 16). Thus, early 
CD8 diff  erentiation appeared to favor the expression of in-
fl  ammatory molecules rather than the classic CD8 functions.
We next aimed to defi  ne TGF-β function in this re-
sponse. TGF-β may be proinfl  ammatory (promoting APC 
diff   erentiation and being a powerful chemoattractant for 
neutrophils, monocytes, and macrophages) or antiinfl  amma-
tory, inhibiting CD8 division (for review see reference 17). 
This latter eff  ect requires the coexpression of two receptor 
types, RI (required for signal transduction) and RII (required 
for ligand capture) (18). However, our single-cell analysis 
showed individual CD8s did not coexpress Tgfbr1 and 
Tgfbr2 (Fig. 1). Thus, expanding CD8 cells may present this 
cytokine in trans, but may have developed mechanisms to es-
cape TGF-β antiproliferation eff  ect, probably because CD8s 
coexpressing RI and RII receptor types were eliminated from 
the cohort of dividing cells. Overall, these gene coexpres-
sion patterns suggest that CD8 T cells may develop eff  ector 
functions early in the immune response, but these eff  ector 
functions may be proinfl  ammatory rather than cytotoxic. As 
described previously in the antilymphocytic choriomeningitis 
virus (LCMV) response (19), anti-HY CD8 T cells also down-
regulated Ifngr2 expression, and thus could not respond to 
IFN-γ (Fig. 1).
PP-CD8s recovered by the peak of the exponential growth 
were very diff  erent from PE-CD8s (Fig. 1). Classical eff  ector 
Figure 1.  Coexpression of “effector” genes in male-specifi  c CD8 
single cells during the primary immune response. Anti-HY CD8 Tg 
single cells were sorted at different points of the response corresponding 
to the following: PE, early expansion phase; PP, peak of exponential 
growth; PL, plateau; and different time points after the end of the con-
traction phase (PM-CD8s). Each row shows the same individual cell 
that is numbered. Each column shows a different gene, representing 
the number of mRNA molecules/cell according to a color log scale. 
Empty symbols represent cells negative for that particular mRNA 
(<2 mRNA molecules). Gray symbols correspond to positive cells where 
mRNA levels were not quantifi  ed. For better visualization of coexpres-
sion patterns, individual cells were ordered by the degree of gene 
coexpression. The same expression patterns were obtained in two inde-
pendent experiments.1196  GENE EXPRESSION IN CD8 DIFFERENTIATION | Peixoto et al.
CD8 mRNAs were now frequently expressed. Importantly, 
these mRNAs were coexpressed by the same cell, which is 
necessary to mediate eff  ective killer functions (15, 16). Thus, 
 36% of PP-CD8s were Ifng mRNA+. For the fi  rst time, a 
substantial fraction of CD8s also expressed Fasl. Considering 
gene coexpression,  45% of PP-CD8s coexpressed both Prf1 
and Gzma or/and Gzmb (Granzymes-Gzms). Coexpression 
of these molecules together with Ifng and Fasl revealed that 
 30% of PP-CD8s might have been able to kill targets using 
either the perforin or the FasL pathway, and a further 30% 
might had the potential to use both pathways simultaneously. 
29% of these T cells could potentially associate IFN-γ kill-
ing to cytotoxicity mediated by other killer molecules. Thus, 
PP-CD8 populations harbor a large cohort of potential killer 
eff  ectors, in contrast to PE-CD8s.
These results allow us, for the fi  rst time, to investigate how 
diff  erent genes belonging to the same diff  erentiation pathway 
become coexpressed by the same cell. Statistic analysis of gene 
association revealed that the gene coexpression was generally 
random, with only Gzms and Fasl associating preferentially 
(Fisher’s exact test: FET P < 0.01). These results have par-
ticular relevance to the current theories of gene association 
during CD8 diff  erentiation (11), as discussed later.
From the peak of the response onwards anti-HY CD8 T 
cells accumulate slowly forming a plateau up to day 15, when 
the contraction phase begins, CD8 T cells reaching steady-
state numbers 1  –2 wk (5). This plateau correlated to a drop 
in eff  ector mRNAs copies in PL-CD8s (Figs. 1 and 2). Sur-
prisingly, diff  erent eff  ector genes also behaved very diff    erently 
during the transition to memory. The expression frequencies 
of Prf and Fasl were relatively maintained, whereas other genes 
down-regulated. However, PM-CD8s lost the coexpression 
of eff  ector killer genes (Fig. 1) reported to be required for 
  effi   cient killer functions.
In contrast to anti-HY cells that are all CD44− and do not 
express eff  ector molecules (5), “naïve” OT-1 cells are very 
cross-reactive and contain CD44int, as well as a few CD44high 
cells (20), and  35% of the cells already expressed Tgfb1. 
(Fig. 1 and Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20062349/DC1). The kinetics of the OT-1 
response (Fig. 3 a) was also more rapid than that of anti-HY 
cells (5). This rapid expansion was peculiar to the OT-1 clone 
because the kinetics of P14 cells response to L. monocytogenes 
GP33 was similar to the anti-HY response (unpublished data). 
However, when similar stages of the response were com-
pared, the gene expression patterns found after L. monocytogenes 
stimulation (Fig. 3, b and c) were very similar to the HY 
response (Figs. 1 and 2). The Tgfb1 was up-regulated, and Tnf 
was induced before any T cell division (Fig. 3 c) and peaked 
in PE-CD8s. In contrast, PE-CD8s showed poor coexpression 
of the cytotoxic mRNAs Prf1 and Gzms. Fasl expression was 
also very rare (Fig. 3, b and c). PP-CD8s were also character-
ized by Prf1 and Gzms coexpression by the same cell, and Fasl 
expression in a large fraction of CD8 T cells. During the 
transition to memory, these diff  erent genes also showed the 
same heterogeneous behavior we found in the anti-HY  response. 
The expression frequencies of both Prf1 and Fasl were relatively 
maintained, whereas Ifng and Gzms were down-regulated. 
The OT-1 PM-CD8s lost coexpression of killer genes in 
a manner similar to anti-HY PM-CD8s. Moreover, we ob-
served this behavior in all individual mice (Fig. 3 c).  However, 
we found that Tgfb1 was less down-regulated (Fig. 3) than 
in anti-HY memory cells (Fig. 1). We are presently investi-
gating if this higher expression of Tgfb1 is a characteristic of 
this cross-reactive clone that expresses some Tgfb1 at the naive 
stage (Fig. S1) or a diff  erent infl  ammatory imprinting of the 
L. monocytogenes response.
We thus conclude that eff  ector genes expression patterns 
in diff  erent T clones (anti-HY or anti-OVA) and in diff  erent 
immune responses (response to male cells or response to 
L. monocytogenes) follow similar rules: the heterogeneous behav-
ior of individual eff  ector genes, the early expression/down-
regulation of proinfl  ammatory molecules, the coexpression 
of killer mRNAs in the same cell at the peak of the immune 
reaction, the maintenance of the expression of certain eff  ec-
tor genes in the PM phase, but the loss of coexpression of 
killer molecules in the eff  ector–memory transition. It must 
Figure 2.  Variation of each gene expression level at different time 
points of the primary immune response. Individual CD8 Tg spleen 
 lymphocytes  specifi  c to the male antigen were recovered at PE (blue 
  diamond), PP (orange square), PL (yellow triangle), and at the memory 
phase 1 mo (green circle) and 2 mo (purple triangle) after immunization; 
30 individual cells were studied at each time point. Negative cells are not 
fi  gured. Results compare the expression levels of each gene in individual 
cells throughout the response, showing the absolute number of mRNAs/
cell plotted in a log scale. They correspond to one of the two independent 
kinetic experiments we performed.JEM VOL. 204, May 14, 2007  1197
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Figure 3.  The primary response to L. monocytogenes immunization. 
OT-1 CD8 Tg cells specifi  c of the OVA antigen were transferred to B6 mice, 
which were immunized with L. monocytogenes OVA. (a) Kinetics of the 
  response. Results show the number of OT-1 cells recovered/mouse at different 
points after immunization and are the mean ± the SEM of three mice/time 
point. (b and c) Coexpression of effector genes at different points of the 
response. OT-1 cells were single-cell sorted, and their gene expression was 
depicted as described in Fig. 1. (c) OT-1 cells were recovered from two dif-
ferent individual mice in each time point. CD69+ cells were activated cells 
that had not yet divided. Gene expression patterns are as described in Fig. 1.1198  GENE EXPRESSION IN CD8 DIFFERENTIATION | Peixoto et al.
be noted that throughout the primary response we found 
cells that responded to the Ag “in vivo,” but did not express 
or coexpress eff  ector molecules. Early in the response, these 
could correspond to cells that did not yet diff  erentiate into 
eff  ector cells. However, the presence of “functionless” cells 
at the peak of the response suggests that not all T cells divid-
ing extensively in vivo necessarily diff  erentiate into eff  ector 
functions. Alternatively, transition to memory may not occur 
simultaneously; these “functionless cells” could correspond 
to CD8s that had already lost eff  ector functions and diff  eren-
tiated into memory cells.
Early T cell differentiation generates 
“infl  ammatory effectors”
The diff  erent gene coexpression patterns of CD8 T cells at 
the beginning or at the end of the exponential expansion 
phase suggested that they could meditate diff  erent functions, 
the former being proinfl  ammatory the latter being cytotoxic. 
Infl  ammation is characterized by local blood fl  ow modifi  ca-
tions and nonspecifi  c trapping, when all types of circulating 
cells initially accumulate in the organ where the infl  amma-
tion takes place (21). We used the anti-HY system to verify 
if T cells recovered early in the expansion phase could medi-
ate such an infl  ammatory process. Indeed, only the anti-HY 
system allows attributing infl  ammatory properties to the T 
cells themselves. When adoptively transferring T cells to test 
for the induction of infl  ammation, we do not risk cotransfer-
ring either bacteria or bacterial products that are present at 
the beginning of the L. monocytogenes response, and that may 
also be able to induce infl  ammatory reactions by themselves.
To study infl   ammatory trapping we isolated anti-HY 
cells at diff  erent points of the immune response and injected 
them directly into the spleen of naive hosts. These hosts were 
  injected i.v. with female target cells loaded or not with the 
HY peptide, and labeled with diff  erent intensities of CFSE. 
In the absence of “eff  ector” CD8 T cells, the target cells 
reached the lymph nodes. When PE-CD8s were injected, 
target cells were prevented from reaching the lymph nodes 
(Fig. 4, a and b) and accumulated in the spleen (Fig. 4 b). Both 
antigen-loaded and nonloaded cells were trapped similarly, as 
it is characteristic of the infl  ammatory component of the trap-
ping reaction (21). PE-CD8s also induced the accumulation 
of host monocytes/granulocytes in the spleen (unpublished 
data). In contrast, these cells were unable to control antigen 
Figure 4.  CD8 effector functions. (a and b) Trapping. Naive or PE-
CD8s anti-HY–specifi  c cells were injected in the spleen of Cd3ε−/− female 
mice. These mice were simultaneously injected i.v. with female CFSE+ 
target cells (a mixture of CFSElow and CFSEhigh targets, the latter loaded 
with the HY-peptide). 1 d later, we quantifi  ed the target cell recovery in 
the spleen and lymph nodes. (a) Gated CFSE+ cells in half of the lymph 
node (control) or total lymph node cells from individual mice injected 
with PE-CD8s. (b) Absolute number of targets in the lymph nodes and 
spleen. (c and d) Antigen loads. (c) Thy1.1+ naive “sensor” cells were in-
jected into mice undergoing the immune reaction at different points of 
the responses. Results show CD69 expression in “sensor” cells 1 d after 
injection. (d) Quantifi  cation of Zfy-1 DNA in the spleen at different days 
after immunization. Similar results were obtained in the bone marrow. 
(e) In vivo killing. Targets were as described in the graphs in (a). CD8 cells 
were naive (control) or recovered at points of the response. Targets and 
CD8s were coinjected into the spleen of Cd3ε−/− female mice. The per-
centage of specifi  c killing was evaluated as compared with the control 
performed in the same day. CD8 T cells and nonpulsed targets remained in 
similar numbers in the spleen during the 6 h required for optimal killing. 
All results are from one of three experiments.JEM VOL. 204, May 14, 2007  1199
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Figure 5.  Correlation between Il7r and Ccr7 expression and the 
coexpression of effector molecules. Each horizontal line shows the 
same individual cell. Columns show different genes and, when colored, 
represent the number of mRNA molecules/cell according to a color log 
scale. Empty symbols represent cells negative for that particular mRNA 
(<2 mRNA molecules). Gray symbols represent positive cells where mRNA 
levels were not quantifi  ed. (a) Il7r-expressing cells were ordered by de-
creasing amounts of Il7r copies/cell. Il7r-negative cells were ordered by 
the degree of effector gene coexpression. (b) Ccr7+ and Ccr7− cells were 
ordered according to the degree of effector gene coexpression. Please 
note that individual Ccr7 + cells did not show major differences in Ccr7 
expression levels.
load (see next section). These results show that eff  ector cells 
are generated very early in the immune response, but they are 
infl  ammatory rather than cytotoxic. Moreover, it is usually 
believed that initiation of infl  ammatory reactions requires the 
presence of “danger” signals provided by pathogens (22). Our 
data demonstrate that T cells themselves can initiate at least 1200  GENE EXPRESSION IN CD8 DIFFERENTIATION | Peixoto et al.
some type of infl  ammatory reactions because in the anti-HY 
system, such danger signals are absent.
“Killer effectors” coexpress killer genes
We next characterized antigen elimination in these mice. 
Antigen loads usually decline by the peak of the immune re-
action, a fi  nding we observed in both these responses. We 
confi  rmed that L. monocytogenes is eliminated at the peak of 
the exponential OT-1 cell growth (14). The CD69 expres-
sion of a new cohort of naive Thy1+ cells injected into mice 
undergoing the anti-HY response indicates that male antigen 
loads in the anti-HY response are also highest at the begin-
ning of the response, declining by the peak of exponential T 
cell growth (Fig. 4 c). In the L. monocytogenes system, we can-
not exclude the presence of cross-presented peptides, whereas 
the anti-HY response relies on direct antigen presentation 
(23). Therefore, we can more accurately quantify antigen 
persistence by the direct quantifi  cation of the male-specifi  c 
Zfy1 gene (zinc fi  nger protein Y-linked) that detects male 
cells even when present at a 10−6 frequency (12). By this di-
rect quantifi  cation, antigen loads were also highest at the be-
ginning of the expansion phase and declined by the peak of 
the exponential T cell growth (Fig. 4 d).
The presence of high antigen doses early on, and its elimi-
nation at the peak of the response could be caused by the pres-
ence of two diff  erent eff  ector cell types with diff  erent properties: 
an early “infl  ammatory eff  ector” mediating infl  ammation, but 
unable to eliminate antigen; and a “killer eff  ector” present only 
at the peak of response that can eliminate antigen, but cannot 
mediate infl  ammation. Alternatively, the antigen elimination 
at the peak of the response could be caused by the presence of 
a much higher number of eff  ector cells. To address these alter-
natives, we aimed to compare the killer capacity of anti-HY 
PE-, PP-, PL-, and PM-CD8s on a per cell basis by injecting 
the same number of CD8s together with target cells directly in 
the spleen. We reasoned that this strategy should guarantee 
each recipient would receive the same number of eff  ectors and 
that both eff  ectors and targets would be present in the same lo-
cation during the in vivo killer assay. Indeed, it is well known 
that CD8s change their homing capacities throughout the 
  immune response. If injected i.v., CD8s recovered at diff  erent 
time points would likely migrate diff  erently, not meeting their 
targets in the same way. This assay showed that PE-CD8s were 
unable to kill target cells. Maximal killing was carried out by 
PP-CD8s. PM-CD8s still maintained some killer activity, likely 
because of their Fasl expression (Fig. 4 d).
Therefore, the eff  ector arm of this immune reaction har-
bors two distinct eff  ector subtypes; a fi  rst infl  ammatory eff  ec-
tor, which is generated before exponential expansion, and 
the classic killer eff  ector, which is only present at the peak of 
the immune reaction.
Correlation of IL7R and CCR7 expression and the expression 
of effector molecules
The kinetics of IL-7R expression in these responses (Fig. 
S2, available at http://www.jem.org/cgi/content/full/jem
.20062349/DC1) was as described in the LCMV response (24). 
The IL-7R expression was fully down-regulated in PE-CD8s 
and progressively up-regulated later on, with some IL-7R− 
cells persisting into the PM phase (24). Because of this 
progressive up-regulation, IL-7R expression levels distrib-
uted as a continuum from negative to IL-7Rhigh–expressing 
cells in PP and PL CD8s (24) (Fig. S2). Because IL-7R re-
ceptor expression was claimed to identify memory   precursors 
(24), we correlated Il7r expression levels to eff  ector gene 
  coexpression (Fig. 5 a). When individual cells were ordered 
according to their Il7r levels, PP-CD8s and PL-CD8s (FET < 
0.01) expressing the highest Il7r levels showed the lowest 
coexpression of eff  ector molecules. These results suggest that 
IL-7Rhigh cells that were identifi  ed as memory precursors (24) 
may be like memory cells, i.e., characterized by the lack of 
killer gene coexpression, and that they may already coexist 
with eff  ectors well before the contraction phase. PP-CD8 
IL-7R+ and IL-7R− cells were believed to have similar ef-
fector functions (24), but this is likely caused by a less pow-
erful discriminatory capacity of previous tests. Indeed, cell 
sorting does not allow separating cells with discrete variations 
of IL-7R expression levels. In contrast, we can identify dis-
crete variations of Il7r expression levels, which may allow a 
better separation of putative memory precursors and eff  ector 
subtypes. However, the Il7r− cells persisting into the memory 
phase also lost eff  ector gene coexpression, and persisted for 
long time periods in the absence of antigen (Fig. 5 a).
The expression of CCR7 subdivides human CD8 memory 
cells into CCR7+ central (TCM) and CCR7− eff  ector (TEM) 
subtypes with very diff  erent properties, but in the mouse, the 
relative role of these cell types, as well as their lineage rela-
tionships, are very controversial (for review see reference 25). 
In the anti-HY response, we found no diff  erences in gene 
expression/coexpression patterns between Ccr7+ and Ccr7− 
PM-CD8s, but this response generated few Ccr7+ memory cells 
in the spleen (Fig. 5 a). However, the response to L.  monocytogenes 
generates abundant CCR7+ PM-CD8, and we also found 
no diff  erences between Ccr7+ and Ccr7− cell eff  ector gene 
coexpression patterns (Fig. 5 b). These results indicate that 
mouse CCR7+ and CCR7− types in primary responses are 
not equivalent to human TCM and TEM subtypes because 
these human populations have very diff  erent eff  ector gene 
coexpression (26).
Modifi  cation of gene expression patterns in the secondary 
immune reaction
We next investigated eff  ector genes expression in secondary 
response CD8s (SCD8s). The anti-HY–primed CD8s re-
spond vigorously in secondary reactions. Maximal cell num-
bers are recovered by day 7, and the contraction phase fi  nishes 
by 2 wk after boosting (5). We expected all eff  ector genes to 
be rapidly up-regulated during this vigorous response. Sur-
prisingly, Fasl and Prf1 expression frequencies (already high 
in PM-CD8s) did not increase by day 4 and were not much 
higher in secondary memory cells (SM-CD8s) than in PM-
CD8s (Fig. 6 a). In contrast, Tgfb1, Ifng, Gzma, and Gzmb JEM VOL. 204, May 14, 2007  1201
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expression (which is rare in PM-CD8s) was rapidly reinduced 
in most cells (Fig. 6 a). SCD8s coexpressed multiple killer 
genes shortly after boosting, and controlled the accumulation 
of male cells even before the secondary expansion phase. The 
antigen concentration never reached the levels found in pri-
mary responses (Fig. 6 b). However, the most surprising as-
pect of this secondary response was the very diff  erent behavior 
of eff  ector genes in the eff  ector–memory transition. In the 
primary reaction, antigen elimination was followed by a drop 
in eff  ector gene expression and a loss in gene coexpression 
(Figs. 1 and 2). In contrast, in the secondary reaction, the ex-
pression of all eff  ector genes was maintained in a substantial 
proportion of cells well after antigen elimination (Fig. 6 a). As 
a consequence, many SM-CD8s coexpressed several killer 
genes simultaneously, i.e., they had a gene expression profi  le 
similar to PP-eff  ectors (Supplemental text, available at http://
www.jem.org/cgi/content/full/jem.20062349/DC1).
It was recently reported that SM cells were more effi   cient 
killers than PM cells (27, 28). This data was generated in the 
anti-LCMV response and interpreted as suggesting that succes-
sive boosting generated more eff  ector–memory cells than the 
primary boosting. However, most of the anti-HY PM-CD8s 
were already CCR7− (Fig. 6), and they did not have the gene 
coexpression we found in SM-CD8s. SM-CD8 gene coex-
pression patterns rather resembled the killer cells recovered at 
the peak of the primary response. Thus, we wondered if SM-
CD8s could, in reality, be eff  ectors while persisting in vivo in 
the absence of Ag. To evaluate this possibility, we compared 
SM-CD8s to PP-CD8s killing on a per cell basis. Surprisingly, 
SM-CD8s persisting in vivo for 2–3 mo after antigen elimina-
tion were even more effi   cient killers than PP-eff  ectors (Fig. 
6 c). These results show that the outcome of primary and sec-
ondary reactions is totally diff  erent. Primary immune responses 
generate transitory eff  ector cells and quiescent memory cells, 
whereas secondary responses generate permanent eff  ector cells 
that persist in vivo in the absence of antigen.
CD8 T cells modify their transcriptional behavior 
in secondary immune responses
It is not yet known how the “noise” induced by stochastic 
gene expression is eventually controlled at single-cell level 
Figure 6.  Secondary responses. PM-CD8s were boosted with male 
cells. (a) Individual cells were sorted at different time points after boosting. 
Results show gene expression frequencies in the PM-CD8 donor cells 
we used in this experiment (yellow bars) and in the secondary response 
at different time points after boosting (blue bars). Results correspond to 
>47 cells per time point. (b) Comparison of Ag loads in the primary 
(orange circle) and secondary (blue circle) responses. Primary and secondary 
hosts were studied simultaneously. Results show CD69 expression in “sensor” 
cells at different time points, as described in Fig. 4 c. The same results 
were obtained in three independent experiments. (c) Comparison of cyto-
toxic capacity of PP-effector cells and SM cells recovered 3 mo after anti-
gen elimination. Killer tests were performed as described in Fig. 4 e. Both 
CD8 populations were studied in the same day, with results corresponding 
to one of two experiments. (d) Quantifi  cation of mRNA expression levels 
in secondary single cells recovered at days 4 (blue diamond), 7 (orange 
square), 15 (yellow triangle), and 33 (green circle) after boosting. Results 
show the number of mRNA copies/cell plotted in a log scale.1202  GENE EXPRESSION IN CD8 DIFFERENTIATION | Peixoto et al.
(9, 11, 29). We observed that transcription levels in SM T 
cells (Fig. 6 d) were very diff  erent from that found in primary 
cells (Fig. 2). Cell–cell variation was much reduced. Para-
doxically, the number of “eff  ector” mRNAs/cell was ap-
proximately one to two logs lower than found in the primary 
response. Thus, the permanent expression of eff  ector genes is 
associated with “stabilization” of mRNA expression in indi-
vidual cells.
DISCUSSION
We describe how multiple eff  ector genes are expressed through-
out CD8 diff  erentiation in in vivo immune responses. The 
results obtained were surprising. They do not support assump-
tions issuing from limited in vitro studies of CD8 responses. 
They are also not compatible with the single theory proposed 
to explain gene association during CD8 diff  erentiation.
Previous studies of eff  ector gene expression in Th1/Tc1 
diff   erentiation concentrated on cytokine expression by T 
cells activated in vitro with peptide or anti-CD3, correlating 
cytokine expression to cell division (1, 2). They reported the 
rapid induction of IL-2 before any division in all T cells. We 
also found that these Tg cells expressed abundant IL-2 after in 
vitro activation (7, 23), but we found very little Il2 expres-
sion in vivo. This in vitro/in vivo diff  erence was also found 
in CD4 responses that express abundant IL-2 after in vitro 
stimulation, but little Il2 in in vivo responses (30).
CD8 eff  ector genes are also believed to be rapidly in-
duced after a few cell divisions (1, 2). However, we found 
that individual eff  ector molecules could be induced at very 
diff  erent time points during the primary response. Infl  amma-
tory genes were expressed before any division. In contrast, 
CD8 cells had diluted CFSE, and underwent major expan-
sion before the majority expressed Ifng Grzms or Fasl. It is 
also assumed that eff  ector genes decline when the antigen is 
eliminated, but not all genes behaved this way. Infl  ammatory 
genes declined when the antigen was abundant, and T cells 
expanded vigorously. Prf1 and Fasl expression were relatively 
maintained for a long time after antigen elimination. There-
fore, during this primary immune response, individual eff  ec-
tor genes could be induced at diff  erent time points, were 
expressed during diff  erent lengths of time, down-regulated at 
diff  erent time points, and, in some cases, not down-regulated 
at all. Importantly, such heterogeneous gene expression is not 
peculiar to TCR-Tg systems, but also occurs in polyclonal 
cells from normal immunized mice (unpublished data).
Several modifi  cations of the transcriptional behavior in 
secondary responses were also unexpected. Memory T cells 
are believed to rapidly reexpress all eff  ector genes after 
  reactivation (31). However, boosting did not modify the 
transcription of Prf1 and Fasl. All other eff  ector genes were 
rapidly reinduced after boosting, but then they became 
permanently transcribed in a large fraction of CD8 T cells 
even after antigen elimination. These results show that dur-
ing CD8 diff  erentiation, the expression of all eff  ector genes 
eventually evolves into an “antigen-independent” permanent 
transcription status, which was unsuspected. This   sustained 
transcription was associated to other major diff  erences in 
SCD8’s transcription behavior. Cell–cell variation was re-
duced. Paradoxically, the number of “eff  ector” mRNAs/cell 
was approximately one to two logs lower than that found 
early in the primary response. It is tempting to speculate 
that such diff  erences are caused by the signal transduction 
modifi  cations we described in memory cells (7). Because 
these eff  ector genes are regulated by several Ca2+-  dependent 
transcription factors (11), and memory cells increase the fre-
quency and reduce the amplitude of Ca2+ transients (7), 
transcription oscillations (32) likely follow the same trend. 
  Increased frequency/decreased amplitude of Ca2+ transients 
and transcription oscillations would simultaneously justify 
SCD8’s reduced mRNA levels, diminished cell–cell variation, 
and sustained transcription.
Our study also allows us to determine, for the fi  rst time, 
how diff  erent eff  ector genes are coexpressed by the same ef-
fector cell. As CD8 eff  ector genes share some regulatory ele-
ments, it was postulated that this sharing would determine 
preferential eff  ector gene coexpression (11). In contrast, we 
found that most of them were coexpressed stochastically, 
even when transcription became permanent in SM cells. Al-
though our study does not address gene regulation, the pre-
sent results indicate that we need to look for diff  erent clues 
to understand how these genes are induced and maintained. 
Because individual eff  ector genes behaved diff  erently, gene-
specifi  c regulatory elements (rather than shared regulatory 
  elements) should have a dominant role in conditioning their 
expression. The random association of eff  ector molecules in 
the same cell further supports that “shared regulatory elements” 
are not suffi   cient to establish preferential gene coexpression. 
This is perhaps not too surprising because many of the 
regulatory factors described as being shared by CD8 eff  ector 
genes (Eomes, NFAT, NF-κB, Ikaros, etc.) are not specifi  c 
to the CD8 diff  erentiation pathway. Other “gene-specifi  c” 
and “pathway-specifi  c” combinations must be involved to 
  engage these regulatory factors in the very diff  erent pathways 
of diff  erentiation they are involved.
This data also refi  nes our previous classifi  cation of the dif-
ferent phases of the immune reaction. Classically, the immune 
response is divided into four sequential successive phases, 
each associated to a peculiar functional behavior: the expan-
sion phase, where cells accumulate, but do not have eff  ector 
functions; the eff  ector phase, where cells express their eff  ector 
functions and eliminate the antigen; and the contraction 
phase, which is initiated after antigen elimination when eff  ec-
tors die and memory precursors are selected to become qui-
escent memory cells in the memory phase. Our data shows 
that during the primary immune response, CD8 T cells actu-
ally go through two successive eff  ector phases, infl  ammatory 
and cytotoxic. Infl  ammatory eff  ectors are generated shortly 
after antigen stimulation, and they mobilize other cells to 
the place where the immune reaction takes place. “Cytotoxic 
eff  ectors” are present at the peak of the exponential T cell 
growth, and they coexpress killer molecules and control anti-
gen loads. PM cells lose killer capacity because they lose killer JEM VOL. 204, May 14, 2007  1203
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genes coexpression. The behavior of CD8 T cells in second-
ary immune reactions diverges even further from the classic 
subdivision of CD8 responses. Thus, SCD8s diff  erentiate into 
killer cells and control antigen loads before the beginning of 
the secondary expansion phase. Moreover, after the antigen 
was fully eliminated in secondary responses CD8s maintain 
the coexpression of eff  ector genes and eff  ector functions per-
manently; they are more effi   cient than the classical killer cells 
that are present at the peak of the primary immune reaction.
It has recently been described that anti-LCMV GP33-
specifi  c memory cells change after boosting, SM cells further 
down-regulating CCR7 expression, killing target cells better 
than PM cells, and increasing their tropism for nonlymphoid 
tissues (27, 28). This data was interpreted as suggesting that 
boosting induces the conversion of central memory T cells 
to eff  ector memory T cells (27, 28). However, both eff  ec-
tors and eff  ector–memory cells are CCR7−, and our data 
suggests that cells present at the end of secondary responses 
are actually effi   cient eff  ectors. Indeed, in both the anti-HY 
and the anti–L. monocytogenes systems, the majority of PM-
CD8s were CCR7−, and thus should be considered   eff  ector–
memory T cells. However, these CCR7− PM-CD8s did 
not coexpress eff  ector genes nor killed targets effi   ciently, 
i.e., were clearly diff  erent from PP-killer cells. Instead of 
comparing primary and SM as was done previously (27, 
28), we compared SM-CD8s to the PP-eff  ector cells. We 
found both cell types shared similar eff   ector gene coex-
pression and that the SM-CD8s killer capacity on a per cell   
basis was superior to that of PP primary eff  ectors. Moreover, 
the anti-HY system has some advantages in establishing that 
such eff  ector cells can persist in the absence of nominal 
  antigen. Indeed, the anti-HY clone is not cross-reactive (20). 
In contrast, anti-LCMV GP-33 cells recognize self-epitopes 
from the dopamine β-monooxygenase responsible for the 
conversion of dopamine to noradrenalin in the suprarenal 
glands, LCMV infection leading to suprarenal infi  ltration, and 
a drop in dopamine levels (33, 34). Thus, the LCMV GP-33 
system does not allow excluding chronic self-stimulation 
as a mechanism for maintenance of memory or eff  ector cell 
types. Globally, our data thus supports the notion that pri-
mary responses predominantly induce short-lived eff  ector 
functions, whereas secondary responses generate a cohort of 
long-lived eff  ector cells that persist in vivo in the absence 
of antigen.
Finally, it might be useful to compare the information 
obtained by this single-cell method to that of more global 
approaches, as the quantitative analysis of gene expression at 
population level in gene expression arrays (35). Arrays are 
relatively easy to perform, and allow screening for virtually 
the entire mouse genome, whereas the present methodol-
ogy is laborious and only allows screening the expression of 
 20 known genes each time. However, our results show that 
single-cell assays give important information that cannot be 
obtained by array studies. We can determine the frequency of 
expression of each gene. In an array’s data, it is impossible to 
determine if a signal is caused by a minority of cells   expressing 
high mRNA levels, or to a majority population expressing 
a gene at lower levels. Indeed, we show that individual genes 
are transcribed at very diff  erent levels. Transcription can range 
from >107 mRNAs/cell (Gzmb and Gzma) to 103 mRNAs/
cell (Tgfb1 and Prf1). Consequently, a single cell express-
ing Gzmb at 106 mRNAs/cell present at 1/1,000 frequency 
may give the same signal as 100% of the cells expressing 
Tgfb1 at 103 mRNAs/cell, i.e., a rare nonrepresentative event 
at 10−3 frequency and a major property shared by all T cells 
may score similarly in population readouts. This major bias 
was evident when we quantifi  ed mRNA expression of the 
same PE-CD8s studied as a population or as single cells (10). 
In the fi  rst case, Gzmb was the most abundant gene expressed 
by the PE population, but our single-cell analysis revealed 
that such a signal was caused by rare cells expressing Gzmb 
at >106 copies/cell. In contrast, PE-CD8 population Tgfb1 
signal was much weaker than that of Gzmb, but our single-
cell analysis revealed that this gene was expressed by >70% of 
PE-CD8s at  103 copies/cell. The other major limitation of 
gene expression arrays is their inability to evaluate if diff  erent 
genes are expressed by the same cell or by diff  erent individual 
cells. Our present data shows that coexpression studies are 
particularly relevant for the understanding of T cell behavior. 
Thus, we determined that proliferating T cells couldn’t re-
spond to the TGF-β they produce, because individual cells 
did not coexpress the Tgfbr1 and Tgfbr2. This fi  nding led us 
to envisage a proinfl  ammatory role of early eff  ectors that we 
confi  rmed by in vivo functional studies. In contrast, because 
individual cells expressing either Tgfbr1 or Tgfbr2 are present 
within this population, a study performed at a population 
level would score positive for both genes. Killer genes co-
expression studies gave important clues on killer potential of 
diff  erent populations. Thus, PE-CD8s (that at a population 
level score positive for both Prf1 and Gzmb) were shown not 
to coexpress these molecules at single-cell level, suggesting 
that they were not cytotoxic, which we did confi  rm by in 
vivo functional tests. Similarly, individual PM-CD8 did not 
coexpress Prf1 and Gzmb, explaining why PM cells are qui-
escent, although they may score positive for these cytotoxic 
mRNAs in genetic arrays (35). It must be noted that, in many 
circumstances, single-cell coexpression of diff  erent  genes 
cannot be evaluated at protein level because, as in the case 
of perforin, Abs recognizing native proteins in the mouse are 
not available. Thus, genetic arrays and single-cell analysis ap-
pear to have diff  erent complementary scopes. Genetic arrays 
are fundamental to identify potentially important genes that 
are diff  erentially expressed in two diff  erent cell sets. Single-
cell analysis, by evaluating diff  erent gene expression frequen-
cies and their coexpression by the same cell, gives important 
information on cell heterogeneity and indicates potentially 
diff  erent T cell properties.
MATERIALS AND METHODS
Naive and memory Tg cells. Naive CD8 cells were obtained from 
C57BL/6 Rag2-defi  cient female mice expressing Tg-TCR specifi  c to the 
male antigen HY(5, 12) or to the OVA peptide (OT-1 cells). PM Tg cells 1204  GENE EXPRESSION IN CD8 DIFFERENTIATION | Peixoto et al.
were obtained from immunized mice 2–6 mo after priming. SM cells were 
obtained 2–3 months after the secondary immune response. In the anti-HY 
response, Tg CD8 T cells were stimulated in the same conditions in primary 
and secondary responses. In brief, 0.5 × 106 Tg lymph node cells and 106 
CD4+ T cells were injected i.v. into Rag2-defi  cient female mice, and im-
munized with 0.5 × 106 male bone marrow cells from Cd3ε-defi  cient mice 
and 5 × 106 female bone marrow cells. In the response to OVA, 106 OT-1 
Tg cells were transferred i.v. into normal B6 mice and immunized i.v. with 
103 L. monocytogenes OVA, which was a gift from L. Lefrançois (University 
of Connecticut Healthcare Center, Farmington, CT). The animal studies 
performed were approved by the Bureau de l’Expérimentation Animale du 
Ministère d’Éducation National, Enseignement Supérieur et Recherche.
Antibodies and immunofl  uorescence. Antibodies used were as follows: 
PE-labeled anti-CD69, biotin-labeled T3.70, anti-Ly-5.2 (104–2.1), Cy-
Chrome–labeled anti-CD8, and FITC-labeled anti–Thy-1.2. Biotinylated 
antibodies were revealed with streptavidin-allophycocyanin, and labeling 
was evaluated in a FACSCalibur (Becton Dickinson).
Evaluation of antigen load. To determine L. monocytogenes loads, livers 
were aseptically removed and separately homogenized in distilled water. 
Bacterial counts in liver homogenates were determined at various intervals 
on BHI agar supplemented with 5 μg/ml erythromycin. We determined 
male antigen loads remaining in immunized mice by two independent 
methods that gave overlapping results. We studied their capacity to activate 
naive Tg cells by injecting 0.5 × 106 naive Thy1.1+ CD69neg Tg cells 
(“sensor cells”) i.v. into mice undergoing immune responses at diff  erent 
time points after immunization and evaluating sensor cell CD69 expression 1 d 
later (13). Because this response relies on direct antigen presentation (23), 
and not cross-presentation, we also quantifi  ed male DNA directly. For that 
purpose, spleen and bone marrow cells were isolated during the immune re-
sponse and samples containing 20 ng of DNA were real-time PCR amplifi  ed 
for the Zfy-1 gene (Zinc fi  nger protein Y-linked) (12).
Trapping. Targets were Ly5.2+ female splenocytes labeled with two con-
centrations of CFSE, 0.5 μM CFSElow, and 5 μM CFSEhigh. The CFSEhigh 
cells were pulsed with 10−6 M HY peptide (36). Anti-HY CD8 Tg cells were 
obtained from naive or immunized mice at diff  erent times after antigen stim-
ulation by magnetic sorting. 0.5 × 106 purifi  ed Tg (>98%) naive or primed 
CD8 Tg cells were injected in the spleen of Ly5.1+ Cd3e-defi  cient mice and 
a mixture of 5 × 106 CFSElow and 5 × 106 CFSEhigh targets were injected 
i.v. Target cell migration to the lymphnodes was evaluated 1 d later.
In vivo cytotoxicity assays. CD8 Tg cells and target cells were as de-
scribed in the previous section. 0.5 × 106 Tg cells and a mixture of 106 
CFSElow and 106 CFSEhigh targets were injected into the spleen of Ly5.1+ 
Cd3e-defi  cient mice. First, we quantifi  ed CFSElow and CFSEhigh cells in the 
spleen and lymph nodes of mice injected with target cells alone or with 
  targets and naive CD8 Tg cells. As expected, naive Tg cells did not modify 
target cell recovery. Thus, specifi  c cytotoxicity was determined by evaluating 
CFSElow and CFSEhigh relative recovery in mice injected either with naive 
Tg cells or diff  erent sets of primed Tg cells, as described previously (37). We 
evaluated the kinetics of CFSEhigh target cells elimination and found maximal 
killing was by 6 h after injection.
Single-cell multiple parametric quantitative RT-PCR. This method 
has previously been described in detail (10). To ensure that each well con-
tained a T cell Cd3e, mRNA was amplifi  ed simultaneously with the other 
genes. To ensure that amplifi  cations performed in diff  erent days could be 
  directly compared, we included two internal standards for quantitative 
  evaluations. The fi  rst was an in vitro–synthesized RNA containing serial 
  dilutions of a known number of molecules, ranging across all expression levels 
and undergoing the same RT and PCR amplifi  cations, which allowed evalua-
tion of both RT and PCR effi   ciencies. The second was a pooled cDNA 
prepared from activated T cells, which contained RNAs from all the genes 
we studied in previously determined known amounts. This second standard 
controlled individual gene amplifi  cation effi   ciencies.
Nomenclature. Throughout this study, we used the genetic nomenclature 
according to the guidelines from the International Committee on Standard-
ized Genetic Nomenclature for Mice for genes and mRNA (http://www
.informatics.jax.org). In this nomenclature, genes and mRNAs have the 
same abbreviation. The mRNAs studied were Perforin (Prf1), Granzyme A 
(Gzma), Granzyme B (Gzmb), FasL (Fasl), IFNγ (Ifng), TGFβ1 (Tgfb1), 
TNFα (Tnf), TNFβ (Lta), IL2 (Il2), IL4 (Il4), IL5 (Il5), IL10 (Il10), IL13 
(Il13), IL15 (Il15), IL21 (Il21), IFNγRII (Ifngr2), TGFβRI (Tgfbr1), 
TGFβRII (Tgfbr2), IL7R (Il7r), CCR7 (Ccr7), and CD3ε (Cd3e).
Statistical analysis. Frequency estimates were determined according to the 
Poisson equations. All diff  erences mentioned in the text were signifi  cant. 
Potential associations or dissociations in the expression of diff  erent genes 
were studied using the two-tailed Fisher’s exact test. This test allows dis-
crimination between random association and preferential gene coexpression, 
and is adequate to evaluate relative small samples. A P value of <0.05 was 
considered statistically signifi  cant.
Online supplemental material. Fig. S1 shows eff  ector genes expression 
in naive OT-1 T cells. Fig. S2 shows expression of IL-7R in anti-HY–
  specifi  c cells. The online version of this article is available at http://www
.jem.org/cgi/content/full/jem.20062349/DC1.
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